Von Willebrand Disease: Basic and Clinical Aspects provides an insight into all aspects of the condition. Since its discovery, von Willebrand disease has been extensively studied and the causative factor deficiency, the understanding of the condition and its treatment has greatly improved. This book summarizes recent research and will help to optimize the management of patients with von Willebrand disease.
This valuable book describes the important and complex role of von Willebrand factor in hemostasis and thrombosis. In addition to the current understanding of its molecular biology, this book gives particular focus to the association between genetic variants of von Willebrand factor and different von Willebrand disease phenotypes. It also reviews the important area of the obstetric and gynecological manifestations of von Willebrand disease, as well as the treatment of acute bleeding.
Written by an international team of contributors it describes the progress in, and difficulties of diagnosing phenotypes and genotypes. Molecular diagnosis of type 1, type 2 and its subgroups, and type 3 von Willebrand disease are presented as well as discussion of the potential future role of gene therapy.
Von Willebrand Disease: Basic and Clinical Aspects is a valuable resource for hematologists in practice and in training, and specialists in thrombosis and hemostasis.
Von Willebrand Disease: Basic and Clinical Aspects provides an insight into all aspects of the condition. Since its discovery, von Willebrand disease has been extensively studied and the causative factor deficiency, the understanding of the condition and its treatment has greatly improved. This book summarizes recent research and will help to optimize the management of patients with von Willebrand disease.
This valuable book describes the important and complex role of von Willebrand factor in hemostasis and thrombosis. In addition to the current understanding of its molecular biology, this book gives particular focus to the association between genetic variants of von Willebrand factor and different von Willebrand disease phenotypes. It also reviews the important area of the obstetric and gynecological manifestations of von Willebrand disease, as well as the treatment of acute bleeding.
Written by an international team of contributors it describes the progress in, and difficulties of diagnosing phenotypes and genotypes. Molecular diagnosis of type 1, type 2 and its subgroups, and type 3 von Willebrand disease are presented as well as discussion of the potential future role of gene therapy.
Von Willebrand Disease: Basic and Clinical Aspects is a valuable resource for hematologists in practice and in training, and specialists in thrombosis and hemostasis.
Recenzijos
"This book certainly helped to enhance my knowledge about von Willebrand disease and even prompted me to present a review of the disease to my colleagues. It is excellently written, appeals to a broad category of readers, and exceeds its stated objectives. I would definitely recommend the book to colleagues." (Doody's, 23 September 2011)
Contributors. Foreword. Preface. 1 Historical perspective on von
Willebrand disease (Erik Berntorp and Margareta Blomback). 2 Biosynthesis
and organization of von Willebrand factor (Sandra L. Haberichter). 3 von
Willebrand factor structure and function (Robert R. Montgomery and Sandra L.
Haberichter). 4 Modulation of von Willebrand factor by ADAMTS13 (Jennifer
Barr and David Motto). 5 Animal models in von Willebrand disease (Cecile V.
Denis, Olivier D. Christophe and Peter J. Lenting0. 6 Classifi cation of von
Willebrand disease (Javier Batlle, Almudena Perez-Rodriguez and Maria
Fernanda Lopez-Fernandez). 7 The epidemiology of von Willebrand disease
(Giancarlo Castaman and Francesco Rodeghiero). 8 Clinical aspects of von
Willebrand disease: bleeding history (Paula D. James and Alberto Tosetto). 9
Laboratory diagnosis of von Willebrand disease: the phenotype (Ulrich Budde
and Emmanuel J. Favaloro). 10 Molecular diagnosis of von Willebrand disease:
the genotype (Anne C. Goodeve and Reinhard Schneppenheim). 11 Clinical,
laboratory, and molecular markers of type 1 von Willebrand disease (David
Lillicrap, Francesco Rodeghiero, and Ian Peake). 12 Clinical, laboratory,
and molecular markers of type 2 von Willebrand disease (Dominique Meyer,
Edith Fressinaud, and Claudine Mazurier). 13 Clinical, laboratory, and
molecular markers of type 3 von Willebrand disease (Luciano Baronciani,
Augusto B. Federici, and Jeroen C.J. Eikenboom). 14 Pediatric aspects of von
Willebrand disease (Jorge Di Paola and Thomas Abshire). 15 Women with von
Willebrand disease (Christine A. Lee, Rezan A. Kadir, and Peter A. Kouides).
16 On the use of desmopressin in von Willebrand disease (Stefan Lethagen,
Augusto B. Federici, and Giancarlo Castaman). 17 The use of plasma-derived
concentrates (Pier Mannuccio Mannucci and Massimo Franchini). 18 Prophylaxis
in von Willebrand disease (Erik Berntorp). 19 Pathophysiology, epidemiology,
diagnosis, and treatment of acquired von Willebrand syndrome (Ulrich Budde,
Augusto B. Federici and Jacob H. Rand). 20 Gene therapy for von Willebrand
disease (Marinee K.L. Chuah, Inge Petrus, and Thierry VandenDriessche).
Index.
Augusto B. Federici, University of Milan, Milan, Italy Christine A. Lee, Oxford Haemophilia & Thrombosis Centre, Oxford, UK Erik E. Berntorp, Lund University, Malmo, Sweden David Lillicrap, Queen s University, Kingston, ON, Canada Robert R. Montgomery, Medical College of Wisconsin; Milwaukee, WI, USA
